These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31785710)

  • 1. A Letter to the Editor Regarding the Original Article by Costa et al: Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
    Biggs M
    J Sex Med; 2019 Dec; 16(12):2043. PubMed ID: 31785710
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
    Costa R; Dunsford M; Skagerberg E; Holt V; Carmichael P; Colizzi M
    J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young adult psychological outcome after puberty suppression and gender reassignment.
    de Vries AL; McGuire JK; Steensma TD; Wagenaar EC; Doreleijers TA; Cohen-Kettenis PT
    Pediatrics; 2014 Oct; 134(4):696-704. PubMed ID: 25201798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
    Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
    J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
    de Vries AL; Steensma TD; Doreleijers TA; Cohen-Kettenis PT
    J Sex Med; 2011 Aug; 8(8):2276-83. PubMed ID: 20646177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of adolescents with gender dysphoria in the Netherlands.
    Cohen-Kettenis PT; Steensma TD; de Vries AL
    Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):689-700. PubMed ID: 22051006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP; Madison CM; Milne NM
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Letter to the Editor Regarding Costa et al. (2015) and Biggs (2019).
    Bartram D
    J Sex Med; 2021 Apr; 18(4):838-839. PubMed ID: 33642236
    [No Abstract]   [Full Text] [Related]  

  • 9. Adolescent development and psychosocial functioning after starting cross-sex hormones for gender dysphoria.
    Kaltiala R; Heino E; Työläjärvi M; Suomalainen L
    Nord J Psychiatry; 2020 Apr; 74(3):213-219. PubMed ID: 31762394
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of juvenile gender dysphoria.
    Hembree WC
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):559-64. PubMed ID: 24468758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puberty suppression in gender identity disorder: the Amsterdam experience.
    Kreukels BP; Cohen-Kettenis PT
    Nat Rev Endocrinol; 2011 May; 7(8):466-72. PubMed ID: 21587245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transgender, transsexualism and gender dysphoria: current developments in diagnostics and health care].
    Nieder TO; Briken P; Richter-Appelt H
    Psychother Psychosom Med Psychol; 2014 Jun; 64(6):232-45. PubMed ID: 24892869
    [No Abstract]   [Full Text] [Related]  

  • 14. [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].
    Matsumoto Y
    Seishin Shinkeigaku Zasshi; 2017; 119(1):42-51. PubMed ID: 30629867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender variance, medical treatment and our responsibility.
    Wæhre A; Schorkopf M
    Tidsskr Nor Laegeforen; 2019 Apr; 139(7):. PubMed ID: 30969045
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for an altered sex ratio in clinic-referred adolescents with gender dysphoria.
    Aitken M; Steensma TD; Blanchard R; VanderLaan DP; Wood H; Fuentes A; Spegg C; Wasserman L; Ames M; Fitzsimmons CL; Leef JH; Lishak V; Reim E; Takagi A; Vinik J; Wreford J; Cohen-Kettenis PT; de Vries AL; Kreukels BP; Zucker KJ
    J Sex Med; 2015 Mar; 12(3):756-63. PubMed ID: 25612159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing normality-persisting barriers: Current socio-demographic characteristics of 350 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Herrmann E; Bojunga J
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):241-246. PubMed ID: 31821578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of transgender surgery.
    Zurada A; Salandy S; Roberts W; Gielecki J; Schober J; Loukas M
    Clin Anat; 2018 Sep; 31(6):878-886. PubMed ID: 29732618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender dysphoria in children and adolescents: a review of recent research.
    Fuss J; Auer MK; Briken P
    Curr Opin Psychiatry; 2015 Nov; 28(6):430-4. PubMed ID: 26382161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the Editor: "Genetic Link Between Gender Dysphoria and Sex Hormone Signaling".
    White PC
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4418-4419. PubMed ID: 30942857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.